1. Home
  2. MRT vs FENC Comparison

MRT vs FENC Comparison

Compare MRT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRT
  • FENC
  • Stock Information
  • Founded
  • MRT 2018
  • FENC 1996
  • Country
  • MRT Turkey
  • FENC United States
  • Employees
  • MRT N/A
  • FENC N/A
  • Industry
  • MRT Rental/Leasing Companies
  • FENC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MRT Consumer Discretionary
  • FENC Health Care
  • Exchange
  • MRT Nasdaq
  • FENC Nasdaq
  • Market Cap
  • MRT 192.2M
  • FENC 156.9M
  • IPO Year
  • MRT N/A
  • FENC 2001
  • Fundamental
  • Price
  • MRT $3.11
  • FENC $6.09
  • Analyst Decision
  • MRT
  • FENC Strong Buy
  • Analyst Count
  • MRT 0
  • FENC 2
  • Target Price
  • MRT N/A
  • FENC $14.00
  • AVG Volume (30 Days)
  • MRT 47.5K
  • FENC 120.6K
  • Earning Date
  • MRT 08-08-2018
  • FENC 03-10-2025
  • Dividend Yield
  • MRT N/A
  • FENC N/A
  • EPS Growth
  • MRT N/A
  • FENC N/A
  • EPS
  • MRT N/A
  • FENC N/A
  • Revenue
  • MRT $18,953,502.00
  • FENC $47,538,000.00
  • Revenue This Year
  • MRT N/A
  • FENC $28.99
  • Revenue Next Year
  • MRT $101.81
  • FENC $63.21
  • P/E Ratio
  • MRT N/A
  • FENC N/A
  • Revenue Growth
  • MRT N/A
  • FENC 123.69
  • 52 Week Low
  • MRT $0.81
  • FENC $3.96
  • 52 Week High
  • MRT $3.89
  • FENC $11.29
  • Technical
  • Relative Strength Index (RSI)
  • MRT 46.23
  • FENC 39.43
  • Support Level
  • MRT $2.80
  • FENC $6.25
  • Resistance Level
  • MRT $3.28
  • FENC $6.90
  • Average True Range (ATR)
  • MRT 0.22
  • FENC 0.34
  • MACD
  • MRT -0.01
  • FENC -0.04
  • Stochastic Oscillator
  • MRT 38.27
  • FENC 19.82

About MRT Marti Technologies Inc.

Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: